October 13, 2025 · Form 4 insider transaction
KASINGER JAMES R. bought 2,114 shares of CRISPR Therapeutics AG, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.; Includes 635 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan.